The State of AI in Pharmaceutical Drug Development


November 18, 2018

This Forbes article was written following a lecture Dr. Niven R. Narain, Ph.D., BERG Co-Founder, President and CEO, gave at Harvard Medical School during the AI Applications Summit for BioPharma in October.

 

The conference provided a useful snapshot into what is happening at the intersection of AI and life sciences and the article describes the author’s ten key observations.

 

To read the full article, click here

Recent news